ATAD2 and breast carcinoma: Expression of ATAD2 correlated with 8q24 amplification among all three cancer types (R2 = 0.47, 0.11, and 0.36 for breast cancers, glioblastomas, and ovarian cancers respectively; p<0.001 in all cases; Table S7), and was 2.6× and 2.5× higher among the cancers relative to normal tissue in breast cancer and glioblastoma, respectively (p<0.001 in both cases).